Qualitas Funds' News

Return to Qualitas Funds news
  • Portfolio transactions
  • Sin categorizar

Qualitas Funds Direct II– Acquisition of Develco Pharma

We are delighted to announce that Develco Pharma has been added to the Qualitas Funds Direct II portfolio. This transaction was led by one of our managers located in Germany.

Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain, from development and approval, to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.